[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5432 Introduced in House (IH)]

<DOC>






117th CONGRESS
  1st Session
                                H. R. 5432

 To amend the Families First Coronavirus Response Act to require group 
   health plans and health insurance issuers to cover T cell immune 
        response testing without the imposition of cost sharing.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 30, 2021

Mrs. Miller-Meeks introduced the following bill; which was referred to 
the Committee on Energy and Commerce, and in addition to the Committees 
    on Ways and Means, and Education and Labor, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL


 
 To amend the Families First Coronavirus Response Act to require group 
   health plans and health insurance issuers to cover T cell immune 
        response testing without the imposition of cost sharing.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``COVID-19 Testing Coverage Act of 
2021''.

SEC. 2. REQUIRING GROUP HEALTH PLANS AND HEALTH INSURANCE ISSUERS TO 
              COVER T CELL IMMUNE RESPONSE TESTING WITHOUT THE 
              IMPOSITION OF COST SHARING.

    Section 6001(a) of the Families First Coronavirus Response Act (42 
U.S.C. 1320b-5 note) is amended--
            (1) in the matter preceding paragraph (1), by inserting 
        ``(or, in the case of tests described in paragraph (3), 
        beginning on or after the date of the enactment of such 
        paragraph)'' after ``the date of the enactment of this Act''; 
        and
            (2) by adding at the end the following new paragraph:
            ``(3) Tests furnished to assess the T cell immune response 
        of an individual to COVID-19.''.
                                 <all>